Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2303]

Matched mutations in the progression of metastatic breast cancer

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Matched mutations in the progression of metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

Whole exome and transcriptome sequencing of resistant ER positive metastatic...

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

Pacritinib versus best available therapy for low platelet Myelofibrosis

Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA

Pacritinib versus best available therapy for low platelet Myelofibrosis ( Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA )

ASH 2016 highlights: breaking new ground in haematology

Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy

ASH 2016 highlights: breaking new ground in haematology ( Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy )

IKZF1 mutations associated with paediatric ALL

Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA

IKZF1 mutations associated with paediatric ALL ( Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA )

ALL: Combining paediatric-type therapy with minimal residual disease

Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

ALL: Combining paediatric-type therapy with minimal residual disease ( Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy )

ASH 2016: AML, CLL and leukaemogenesis latest

Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA

ASH 2016: AML, CLL and leukaemogenesis latest ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )

Venetoclax plus cytarabine in elderly AML patients

Dr Andrew Wei - Alfred Hospital, Melbourne, Australia

Venetoclax plus cytarabine in elderly AML patients ( Dr Andrew Wei - Alfred Hospital, Melbourne, Australia )

Remissions following anti-CD22 CAR therapy in children with relapsed ALL

Dr Terry Fry - National Cancer Institute, Bethesda, USA

Remissions following anti-CD22 CAR therapy in children with relapsed ALL ( Dr Terry Fry - National Cancer Institute, Bethesda, USA )

Mutational drivers of thyroid cancer

Dr Alexsandr Lavrov - N.I.Pirogov Russian National Research Medical University...

Mutational drivers of thyroid cancer ( Dr Alexsandr Lavrov - N.I.Pirogov Russian National Research Medical University, Moscow, Russia )

Gold nanoparticles and cancer treatment

Bas Bavelaar - University of Oxford, Oxford, UK

Gold nanoparticles and cancer treatment ( Bas Bavelaar - University of Oxford, Oxford, UK )

Towards delivering truly personalised therapy for oesophageal cancer

Prof Tim Underwood - University of Southampton, Southampton, UK

Towards delivering truly personalised therapy for oesophageal cancer ( Prof Tim Underwood - University of Southampton, Southampton, UK )

More from ecancer